Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease.

Fishbane S, Spinowitz BS, Wisemandle WA, Martin NE.

Kidney Int Rep. 2019 May 22;4(9):1235-1247. doi: 10.1016/j.ekir.2019.05.010. eCollection 2019 Sep.


Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease.

Fishbane S, Singh B, Kumbhat S, Wisemandle WA, Martin NE.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1204-1214. doi: 10.2215/CJN.11631017. Epub 2018 Jun 19.


Pharmacokinetic and Pharmacodynamic Equivalence of Epoetin Hospira and Epogen After Single Subcutaneous Doses to Healthy Male Subjects.

Stalker D, Reid S, Ramaiya A, Wisemandle WA, Martin NE.

Clin Ther. 2016 Aug;38(8):1778-88. doi: 10.1016/j.clinthera.2016.06.010. Epub 2016 Jul 26.


A phase II/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates.

Chrysostomou C, Schulman SR, Herrera Castellanos M, Cofer BE, Mitra S, da Rocha MG, Wisemandle WA, Gramlich L.

J Pediatr. 2014 Feb;164(2):276-82.e1-3. doi: 10.1016/j.jpeds.2013.10.002. Epub 2013 Nov 14.


Annual changes in total body fat and fat-free mass in children from 8 to 18 years in relation to changes in body mass index. The Fels Longitudinal Study.

Siervogel RM, Maynard LM, Wisemandle WA, Roche AF, Guo SS, Chumlea WC, Towne B.

Ann N Y Acad Sci. 2000 May;904:420-3. No abstract available.


Total-body and regional bone mineral content and areal bone mineral density in children aged 8-18 y: the Fels Longitudinal Study.

Maynard LM, Guo SS, Chumlea WC, Roche AF, Wisemandle WA, Zeller CM, Towne B, Siervogel RM.

Am J Clin Nutr. 1998 Nov;68(5):1111-7.


Supplemental Content

Loading ...
Support Center